8 June 2026
Congratulations to our participants for their wonderful energy and dedication!
news from the crcm
8 June 2026
Inserm's national science culture event returned for its 6th edition.
2 June 2026
Scaglione and Gaillard show that the SLX4 SAP domain selectively binds four-way branched DNA structures. Their findings identify CDK1 phosphorylation as a molecular switch that inhibits DNA binding while promoting MUS81 interaction, thereby temporally controlling distinct SAP functions.
1 June 2026
At the CRCM, the PEP unit works on a daily basis to promote equality […]
6 May 2026
Applications are open for an ambitious program spanning fundamental mechanisms and translational and clinical applications.
6 May 2026
29 April 2026
The CRCM is recruiting a Group Leader to establish a new research team within the Department of Onco-Hematology and Immuno-Oncology
29 April 2026
Christophe DE LA ROCHE SAINT ANDRÉ A passionate researcher, dedicated educator, and well-known figure at […]
10 April 2026
Our research is funded by INCA and the Japanese company ASPIRE as part of a Franco-Japanese collaborative program aimed at improving our understanding of the mechanisms underlying the dysregulation of the EZH2 enzyme in leukemia. Our goal is to shed light on the regulatory mechanisms of EZH2’s oncogenic activity, which could serve as a therapeutic target.
2 April 2026
The Immunomonitoring Platform is recruiting for an ambitious research project on immune biomarkers with high clinical impact.
31 March 2026
Our team is offering an innovative project on replication and genome stability in yeast. […]
31 March 2026
CRCM offers 31 PhD projects covering a wide range of topics in cancer research. These projects are proposed within the doctoral schools ED658 and ED659 and are accessible through their competitive selection process.